reflux
Probiotics: does the hype exceed the evidence?
Despite the growing interest in probiotics, what does the evidence tell us and what advice should pharmacists be giving their customers? It seems that rising awareness of the link between …
Research roundup
Debbie Rigby takes a look at the latest in research news A primer on medicinal cannabis safety and potential adverse effects The aim of this review is to discuss the …
Spreading the word about GORD
Considering the key factors involved in proton pump Inhibitor therapy may assist pharmacists in initiating successful step-down attempts Gastro-oesophageal reflux disease (GORD) is a common complaint among the general community. …
The guts of the problem
Due to the high prevalence of reflux symptoms in the general community and an array of over-the-counter options, many people turn to their local pharmacist first for treatment advice Despite …
The silent reflux: an aerodigestive conundrum
Laryngopharyngeal—or silent—reflux is a significant cause of refractory ENT symptoms. Yet, despite its prevalence and associated risks, it remains underdiagnosed and undertreated. By Dr Brett MacFarlane, PhD, BPharm (Hons), senior pharmacist, …
Caring for kids
Leading pharmacist calls for more guidelines on colic, constipation and reflux in infants, as new survey shows 99% of pharmacists field questions on these disorders A new survey has found …
Acid suppressants for babies don’t work
GPs are over-prescribing acid suppressant medicines for babies with GORD and reflux, new research has found The report, in Archives of Disease in Childhood, is based on a prospective study …